Organization
Laboratory of Molecular Biology, NCI, NIH, Bethesda, MD
4 abstracts
Abstract
Effect of rituximab on remissions without minimal residual disease and immunogenicity in patients with relapsed/refractory hairy cell leukemia receiving moxetumomab pasudotox.Org: Laboratory of Molecular Biology, NCI, NIH, Bethesda, MD, Laboratory of Pathology, NCI, NIH, Bethesda, MD, Office of Research Nursing, NCI, NIH, Bethesda, MD, Hematology Service, DLM, NIH, Bethesda, MD,
Abstract
Genomic characterization of somatic mutations by race and ethnicity in pancreatic cancer defined through AACR project GENIE.Org: Laboratory of Molecular Biology, NCI, NIH, Bethesda, MD, National Cancer Institute, Vilnius, Lithuania, National Institutes of Health All of Us Research Program,
Abstract
Differential expression analysis of circRUNX1 in patients with early resected EGFR-mutant NSCLC.Org: Pangaea Oncology, Laboratory of Molecular Biology, NCI, NIH, Bethesda, MD, Surgical Oncology, Henan Cancer Hospital/Affiliated Cancer Hospital of Zhengzhou University, Institute of Biomedical & Health Sciences, Hiroshima University, University of Granada,
Abstract
Analysis of systemic immune changes in patients with advanced cancer treated with immunotoxin LMB-100 and tofacitinib.Org: National Cancer Insititute, Developmental Therapeutics Branch, Nihon Medi-Physics, Epidemiology and Biostatistics, Thoracic and GI Malignancies Branch,